After Hours
$
55.23
Change
-0.20 -0.36%
Volume
Volume 10,303
May 23, 2022, 4:23 p.m.
Quotes are delayed by 20 min
Previous close
$ 54.40
$ 55.43
Change
+1.03 +1.89%
Day low
Day high
$54.81
$55.88

52 week low
52 week high
$46.93
$58.10

Market cap
$135.76B
Average volume
2.23M
P/E ratio
18.98
Rev. per Employee
$467,643
EPS
2.92
Dividend
N/A
Div yield
2.27%
Ex dividend date
5/3/21
MarketWatch News on SNY
-
Sanofi Receives Another Approval for Blockbuster Drug Dupixent
- Barron's Online
-
CureVac and Glaxo Begin Testing New 'Second Generation' Covid-19 Vaccine
- Barron's Online
-
5 Critical Decisions That Await the New FDA Chief
- Barron's Online
-
Pfizer Steps Ahead of Glaxo in Race for Maternal RSV Vaccine
- Barron's Online
-
Moderna CEO Vows to Grow Vaccine Business as Competition Mounts
- Barron's Online
-
Russia Has Attacked Ukraine. Markets Aren’t Ready for the Fallout.
- Barron's Online
-
Sanofi and Glaxo Report Dual Disappointments. The Stocks Are Holding Up.
- Barron's Online
-
Moderna Is in Talks to Open U.K. Factory
- Barron's Online
-
Regeneron Stock Fell Despite Strong Earnings. This Is Why.
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
Analysts See a 9.5% Upside for SNY Stock over the Next Year
- MarketRealist.com
-
Analysts’ Recommendations for Valeant in June
- MarketRealist.com
Other News on SNY
-
Galapagos: Can The Company Turn Around?
- Seeking Alpha
-
How Novo Nordisk Will Protect Insulin Sales
- Motley Fool
-
BioMarin: A Good Anchor For Your Biotech Portfolio
- Seeking Alpha
-
Rallybio in-licenses preclinical antibody candidate from Sanofi
- Seeking Alpha
-
Bristol-Myers Has the Stalest Product Line, Says Evaluate
- GuruFocus.com
-
Why GSK May Have Bet Too Big on a Pandemic Pipeline
- Motley Fool
-
3 Top Biotech Stocks to Buy Right Now
- Motley Fool
- Loading more headlines...
Press Releases on SNY
-
- Stock Traders Daily
-
Heart Failure Treatment Offers Hope to Diabetics
- Financial News Media
-
Heart Failure Treatment Offers Hope to Diabetics
- PR Newswire - PRF
-
- Stock Traders Daily
-
- Stock Traders Daily
-
Sanofi SNY Investment Analysis and Advice
- Stock Traders Daily
-
Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027
- Financial News Media
-
Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027
- PR Newswire - PRF
-
Learn to Evaluate Sanofi (SNY) using the Charts
- Stock Traders Daily
-
Sanofi SNY Technical Pivots with Risk Controls
- Stock Traders Daily
-
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com